Candidates for thrombolytic treatment in acute ischaemic stroke - Where are our patients in Hong Kong?

Journal of Accident and Emergency Medicine

Volumn 16, Issue 6, 1999, Pages 412-417

  Siu, Y C A ^a   Wong, T W ^a   Lau, C C ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Acute ischaemic stroke; Delay; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ANAMNESIS; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DISEASE SEVERITY; DRUG CONTRAINDICATION; FEMALE; FIBRINOLYTIC THERAPY; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; STROKE; SYSTOLIC BLOOD PRESSURE; TIME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CEREBROVASCULAR ACCIDENT; FEMALE; FIBRINOLYTIC AGENTS; HONG KONG; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032710380     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-7.
2. Food and Drug Administration. Newsletter. Washington, DC: FDA, 18 January 1996.
3. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997;350:607-14.
4. Barsan WG, Brott TG, Broderick JP, et al. Time of hospital presentation in patients with acute stroke. Arch Intern Med 1993;153:2558-61.
5. Azzimondi G, Bassein L, Fiorani L, et al. Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment. Stroke 1997;28:537-42.
6. Zweifler RM, Brody ML, Graves GC, et al. Intravenous t-PA for acute ischaemic stroke: therapeutic yield of a stroke code system. Neurology 1998;50:501-3.
7. Department of Health, Hong Kong Government. Annual report (1994/5). Hong Kong: Hong Kong Government, 1995 :51.
8. Cote R, Battista RN, Wolfson C, et al. The Canadian neurological scale: validation and reliability assessment. Neurology 1989;39:638-43.
9. Kothari R, Jauch E, Broderick J, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med 1999;33:3-8.
10. Feldmann E, Gordon N, Brooks JM, et al. Factors associated with early presentation of acute stroke. Stroke 1993;24:1805-10.
11. Harper GD, Haigh RA, Potter JF, et al. Factors delaying hospital admission after stroke in Leicestershire. Stroke 1992;23:835-8.
12. Kay R, Woo J, Poon WS. Hospital arrival time after onset of stroke. J Neurol Nerurosurg Psychiatry 1992;55:973-4.
13. O'Connor R, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischaemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 1999;33:9-14.
14. Pepe PE, Zachariah BS, Sayre MR, et al. Ensuring the chain of recovery for stroke in your community. Acad Emerg Med 1998;5:352-8.
15. Samsa GP, Cohen SJ, Goldstein LB, et al. Knowledge of risk among patients at increased risk for stroke. Stroke 1997;28: 916-21.
16. Williams LS, Bruno A, Rouch D, et al. Stroke patients knowledge of stroke: influence on time of presentation. Stroke 1997;28:912-15.
17. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998;279:1288-92.
18. Alberts MJ, Perry A, Dawson DV, et al. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992;23:352-6.
19. Wong TW, Lau CC, Pang KC. A review of prehospital care provided by ambulance attendants with extended training in Hong Kong. Hong Kong Journal of Emergency Medicine 1996;3:13-18.
20. Kothari R, Barsan W, Bott T, et al. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke 1995;26: 937-41.
21. Smith WS, Isaacs M, Corry MD. Accuracy of paramedic identification of stroke and transient ischemic attack in the field. Prehospital Emergency Care 1998;2:170-5.
22. Kothari R, Brott T, Broderick JP, et al. Emergency physicians: accuracy in the diagnosis of stroke. Stroke 1995; 26:2238-41.
23. Libman RB, Wirkowski E, Alvir J, et al. Conditions that mimic stroke in the emergency department. Implication for acute stroke trials. Arch Neurol 1995;52:1119-22.
24. Huff JS. Acute stroke intervention: where are the patients? (abstract). Acad Emerg Med 1997;4:373.
25. Heller MB, Kunnel B, Arcona S. Thrombolytics and stroke: what do emergency medicine residents perceive? (abstract). Ann Emerg Med 1998;32:S32.
26. Aziz N, Williams SR, Williams CM, et al. The effect of FDA approval of thrombolytic therapy on the management of acute stroke in the emergency department (abstract). Ann Emerg Med 1998;32:S42.
27. Schriger DL, Kalafut M, Sidney S, et al. Cranial computed tomography in acute stroke. Physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998;279:1293-7.
28. Caplan LR, Mohr JP, Kistler JP, et al. Should thrombolytic therapy be the first-line treatment for acute ischaemic stroke? Thrombolysis - not a panacea for ischaemic stroke. N Engl J Med 1997;337:1309-10, 1313.
29. Furlan AJ, Kanoti G. When is thrombolysis justified in patients with acute ischaemic stroke? A bioethical perspective. Stroke 1997;28:214-18.
30. Grotta J. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? tPA - the best current option for most patients. N Engl J Med 1997;337:1310-12, 1313.
31. European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolyisis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995;274: 1017-25.